The Effect of Effervescent Alendronate on Bone Turnover

Summary

64 postmenopausal women are randomized to treatment with either effervescent and buffered alendronate or conventional alendronate -both 70mg weekly for 16 weeks to see if bone turnover is suppressed to the same extent as in the conventional formulation with the effervescent form.

Timeline

Start

2021-10-01

Primary completion

2022-09-01

Completion

2022-12-01

Drugs

Indications